HIF1A and neoplasm: EGCG exhibits strong hypomethylating potential and also inhibits tumor angiogenesis in xenograft models through down-regulation of vascular endothelial growth factor A (VEGFA) and hypoxia inducible factor 1 alpha (HIF1α) in endometrial cancer [116].